Quiz|Articles|November 30, 2025
Dermatology Times Spot Test: November 30, 2025
Author(s)Marie Bosslett, Assistant Editor
Listen
0:00 / 0:00
Key Takeaways
- The weekly quiz series enhances understanding of dermatology topics, trends, and breakthroughs, focusing on the November print issue.
- Readers are encouraged to contribute quiz questions, promoting engagement and collaboration within the dermatology community.
Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series!
Advertisement
Dermatology Times presents: Spot Test!
Each week, dive into a series of thought-provoking questions designed to test your understanding of essential topics, trends, and breakthroughs in dermatology. This week, we'll focus on insights from our
Do you have a set of quiz questions to share? Contact editor Marie Bosslett at
According to our cover story, which barrier contributes most significantly to delays in CSU diagnosis?
In the article, "Psoriasis Care Evolves as Oral IL-23 Blockers Show Lasting Control," which dermatologist said this?
“We’re not practicing insurance-based medicine. We should be practicing evidence-based medicine.”
How does denifanstat differ from clascoterone and spironolactone for acne?
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Reviewing Type 2 Inflammation Through a Different Lens
3
Derm Dispatch: What 'Free to Be Me' Means to Tori Spelling and Stella McDermott
4
How Clinicians are Navigating JAK Inhibitors and Patient Expectations in Alopecia Areata
5
